Mycobacterium tuberculosis–specific (M. tuberculosis–specific) T cell responses associated with immune control during asymptomatic latent tuberculosis infection (LTBI) remain poorly understood. Using a nonhuman primate aerosol model, we studied the kinetics, phenotypes, and functions of M. tuberculosis antigen-specific T cells in peripheral and lung compartments of M. tuberculosis–infected asymptomatic rhesus macaques by longitudinally sampling blood and bronchoalveolar lavage, for up to 24 weeks postinfection. We found substantially higher frequencies of M. tuberculosis–specific effector and memory CD4+ and CD8+ T cells producing IFN-γ in the airways compared with peripheral blood, and these frequencies were maintained throughout the study period. Moreover, M. tuberculosis–specific IL-17+ and IL-17+IFN-γ+ double-positive T cells were present in the airways but were largely absent in the periphery, suggesting that balanced mucosal Th1/Th17 responses are associated with LTBI. The majority of M. tuberculosis–specific CD4+ T cells that homed to the airways expressed the chemokine receptor CXCR3 and coexpressed CCR6. Notably, CXCR3+CD4+ cells were found in granulomatous and nongranulomatous regions of the lung and inversely correlated with M. tuberculosis burden. Our findings provide insights into antigen-specific T cell responses associated with asymptomatic M. tuberculosis infection that are relevant for developing better strategies to control TB.
Uma Shanmugasundaram, Allison N. Bucsan, Shashank R. Ganatra, Chris Ibegbu, Melanie Quezada, Robert V. Blair, Xavier Alvarez, Vijayakumar Velu, Deepak Kaushal, Jyothi Rengarajan
Title and authors | Publication | Year |
---|---|---|
Soluble immune mediators orchestrate protective in vitro granulomatous responses across Mycobacterium tuberculosis complex lineages
Arbués A, Schmidiger S, Reinhard M, Borrell S, Gagneux S, Portevin D |
eLife | 2025 |
IL-27 alters inflammatory cytokine expression and limits protective immunity against Mycobacterium tuberculosis in a neonatal BCG vaccination model.
Bradford SD, Ryan KJ, Divens AM, Povroznik JM, Bonigala S, Robinson CM |
Frontiers in immunology | 2024 |
BCG-booster vaccination with HSP90-ESAT-6-HspX-RipA multivalent subunit vaccine confers durable protection against hypervirulent Mtb in mice.
Kwon KW, Choi HG, Kim KS, Park SA, Kim HJ, Shin SJ |
npj Vaccines | 2024 |
Rare Variable M. tuberculosis Antigens induce predominant Th17 responses in human infection
Ogongo P, Wassie L, Tran A, Columbus D, Sharling L, Ouma G, Ouma SG, Bobosha K, Lindestam Arlehamn CS, Gandhi NR, Auld SC, Rengarajan J, Day CL, Altman JD, Blumberg HM, Ernst JD |
2024 | |
High-parameter phenotypic characterization reveals a subset of human Th17 cells that preferentially produce IL-17 against M. tuberculosis antigen.
Ogongo P, Tran A, Marzan F, Gingrich D, Krone M, Aweeka F, Lindestam Arlehamn CS, Martin JN, Deeks SG, Hunt PW, Ernst JD |
Frontiers in immunology | 2024 |
Inhibition of Indoleamine-2,3-dioxygenase improves immune responses and is safe for concurrent use with antiretroviral therapy
Bindu Singh, Riti Sharan, Gayathri Ravichandran, Ruby Escobedo, Vinay Shivanna, Edward J. Dick Jr., Shannan Hall-Ursone, Garima Arora, Xavier Alvarez, Dhiraj K. Singh, Deepak Kaushal, Smriti Mehra |
JCI Insight | 2024 |
Adolescent BCG revaccination induces a phenotypic shift in CD4+ T cell responses to Mycobacterium tuberculosis
Dintwe OB, Ballweber Fleming L, Voillet V, McNevin J, Seese A, Naidoo A, Omarjee S, Bekker LG, Kublin JG, De Rosa SC, Newell EW, Fiore-Gartland A, Andersen-Nissen E, McElrath MJ |
Nature Communications | 2024 |
TB/FLU-06E Influenza Vector-Based Vaccine in the Complex Therapy of Drug-Susceptible and Drug-Resistant Experimental Tuberculosis.
Shurygina AS, Zabolotnykh NV, Vinogradova TI, Vitovskaya ML, Dogonadze MZ, Vasilyev KA, Buzitskaya ZV, Yablonskiy PK, Lioznov DA, Stukova MA |
Pharmaceutics | 2024 |
Concurrent TB and HIV therapies effectively control clinical reactivation of TB during co-infection but fail to eliminate chronic immune activation
Kaushal D, Sharan R, Zou Y, Lai Z, Singh B, Shivanna V, Dick E Jr, Hall-Ursone S, Khader S, Mehra S, Alvarez X, Rengarajan J |
Research Square | 2024 |
MINCLE and TLR9 agonists synergize to induce Th1/Th17 vaccine memory and mucosal recall in mice and non-human primates
Woodworth JS, Contreras V, Christensen D, Naninck T, Kahlaoui N, Gallouët AS, Langlois S, Burban E, Joly C, Gros W, Dereuddre-Bosquet N, Morin J, Liu Olsen M, Rosenkrands I, Stein AK, Krøyer Wood G, Follmann F, Lindenstrøm T, Hu T, Le Grand R, Pedersen GK, Mortensen R |
Nature Communications | 2024 |
Protein kinase D1 in myeloid lineage cells contributes to the accumulation of CXCR3(+)CCR6(+) nonconventional Th1 cells in the lungs and potentiates hypersensitivity pneumonitis caused by S. rectivirgula.
Snyder JD, Yoon TW, Lee S, Halder P, Fitzpatrick EA, Yi AK |
Frontiers in immunology | 2024 |
Immune correlates of protection as a game changer in tuberculosis vaccine development.
Wang J, Fan XY, Hu Z |
NPJ vaccines | 2024 |
Progress of CCL20-CCR6 in the airways: a promising new therapeutic target
Li YJ, Geng WL, Li CC, Wu JH, Gao F, Wang Y |
Journal of Inflammation (London, England) | 2024 |
M. tuberculosis antigen-responsive IL17+ CD4 T cells are disproportionately spared in ART-suppressed HIV
Ogongo P, Tran A, Marzan F, Gingrich D, Krone M, Aweeka F, Arlehamn CS, Martin JN, Deeks SG, Hunt PW, Ernst JD |
2023 | |
Host Immunity to Mycobacterium tuberculosis Infection Is Similar in Simian Immunodeficiency Virus (SIV)-Infected, Antiretroviral Therapy-Treated and SIV-Naïve Juvenile Macaques
Larson EC, Ellis AL, Rodgers MA, Gubernat AK, Gleim JL, Moriarty RV, Balgeman AJ, Menezes YK, Ameel CL, Fillmore DJ, Pergalske SM, Juno JA, Maiello P, White AG, Borish HJ, Godfrey DI, Kent SJ, Ndhlovu LC, O\u2019Connor SL, Scanga CA |
Infection and immunity | 2023 |
Liposomal delivery system/adjuvant for tuberculosis vaccine
Moradi M, Vahedi F, Abbassioun A, Ramezanpour Shahi A, Sholeh M, Taheri\u2010Anganeh M, Dargahi Z, Ghanavati R, Khatami SH, Movahedpour A |
Immunity, Inflammation and Disease | 2023 |
T cells in health and disease.
Sun L, Su Y, Jiao A, Wang X, Zhang B |
Signal Transduction and Targeted Therapy | 2023 |
Airway T cells are a correlate of IV BCG-mediated protection against tuberculosis inrhesus macaques
Darrah PA, Zeppa JJ, Wang C, Irvine EB, Bucsan AN, Rodgers MA, Pokkali S, Hackney JA, Kamath M, White AG, Borish HJ, Frye LJ, Tomko J, Kracinovsky K, Ling Lin P, Klein E, Scanga CA, Alter G, Fortune SM, Lauffenburger DA, Flynn JL, Seder RA, Maiello P, Roederer M |
Cell Host & Microbe | 2023 |
Transcriptional signatures measured in whole blood correlate with protection against tuberculosis in inbred and outbred mice.
Kurtz SL, Rydén P, Elkins KL |
PloS one | 2023 |
CXCR3 Provides a Competitive Advantage for Retention of Mycobacterium tuberculosis-Specific Tissue-Resident Memory T Cells Following a Mucosal Tuberculosis Vaccine
Armitage E, Quan D, Flórido M, Palendira U, Triccas JA, Britton WJ |
Human vaccines | 2023 |
A novel adjuvant formulation induces robust Th1/Th17 memory and mucosal recall responses in Non-Human Primates
Woodworth JS, Contreras V, Christensen D, Naninck T, Kahlaoui N, Gallouët AS, Langlois S, Burban E, Joly C, Gros W, Dereuddre-Bosquet N, Morin J, Olsen ML, Rosenkrands I, Stein AK, Wood GK, Follmann F, Lindenstrøm T, LeGrand R, Pedersen GK, Mortensen R |
2023 | |
Antiretroviral therapy timing impacts latent tuberculosis infection reactivation in a tuberculosis/simian immunodeficiency virus coinfection model
Riti Sharan, Shashank R. Ganatra, Allison N. Bucsan, Journey Cole, Dhiraj K. Singh, Xavier Alvarez, Maya Gough, Cynthia Alvarez, Alyssa Blakley, Justin Ferdin, Rajesh Thippeshappa, Bindu Singh, Ruby Escobedo, Vinay Shivanna, Edward J. Dick, Jr., Shannan Hall-Ursone, Shabaana Khader, Smriti Mehra, Jyothi Rengarajan, Deepak Kaushal |
Journal of Clinical Investigation | 2022 |
Cytokine Receptors—Regulators of Antimycobacterial Immune Response
M Druszczyńska, M Godkowicz, J Kulesza, S Wawrocki, M Fol |
International journal of molecular sciences | 2022 |
Mycobacterium tuberculosis impedes CD40-dependent notch signaling to restrict Th17 polarization during infection
A Enriquez, J Sia, H Dkhar, S Goh, M Quezada, K Stallings, J Rengarajan |
iScience | 2022 |
Development and Testing of a Spray-Dried Tuberculosis Vaccine Candidate in a Mouse Model
M Gomez, M Ahmed, S Das, J McCollum, L Mellett, R Swanson, A Gupta, N Carrigy, H Wang, D Barona, S Bachchhav, A Gerhardt, C Press, M Archer, H Liang, E Seydoux, R Kramer, P Kuehl, R Vehring, S Khader, C Fox |
Frontiers in pharmacology | 2022 |
Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control
Gideon HP, Hughes TK, Tzouanas CN, Wadsworth MH II, Tu AA, Gierahn TM, Peters JM, Hopkins FF, Wei JR, Kummerlowe C, Grant NL, Nargan K, Phuah JY, Borish HJ, Maiello P, White AG, Winchell CG, Nyquist SK, Ganchua SK, Myers A, Patel KV, Ameel CL, Cochran CT, Ibrahim S, Tomko JA, Frye LJ, Rosenberg JM, Shih A, Chao M, Klein E, Scanga CA, Ordovas-Montanes J, Berger B, Mattila JT, Madansein R, Love JC, Lin PL, Leslie A, Behar SM, Bryson B, Flynn JL, Fortune SM, Shalek AK |
Immunity | 2022 |
Vaccination inducing durable and robust antigen-specific Th1/Th17 immune responses contributes to prophylactic protection against Mycobacterium avium infection but is ineffective as an adjunct to antibiotic treatment in chronic disease
Lee JM, Park J, Reed SG, Coler RN, Hong JJ, Kim LH, Lee W, Kwon KW, Shin SJ |
Virulence | 2022 |
T helper profile in pregnant women recovered from COVID-19
Tartaglia E, Bordoni V, Oliva A, Vergori A, Girardi E, Antinori A, Agrati C, Liuzzi G |
Journal of Reproductive Immunology | 2022 |
Editorial: The importance of Th17/Treg imbalance in asthma and COPD development and progression
Lopes FD, Tibério ID, Leme A, Fairclough L |
Frontiers in immunology | 2022 |
IL-15 Superagonist N-803 Enhances IFN-γ Production of MAIT Cells in SIV+ Macaques
Ellis-Connell AL, Balgeman AJ, Kannal NM, Hansen Chaimson K, Batchenkova A, Safrit JT, O\u2019Connor SL |
Infection and immunity | 2022 |
Tissue resident-like CD4+ T cells secreting IL-17 control Mycobacteria tuberculosis in the human lung
Paul Ogongo, Liku Tezera, Amanda Ardain, Shepherd Nhamoyebonde, Duran Ramsuran, Alveera Singh, Abigail Ngoepe, Farina Karim, Taryn Naidoo, Khadija Khan, Kaylesh Dullabh, Michael Fehlings, Boon Heng Lee, Alessandra Nardin, Cecilia Lindestam Arlehamn, Alessandro Sette, Samuel M Behar, Adrie JC Steyn, Rajhmun Madansein, Henrik N. Kløverpris, Paul T Elkington, Alasdair Leslie |
Journal of Clinical Investigation | 2021 |
Exaggerated IL-17A activity in human in vivo recall responses discriminates active tuberculosis from latent infection and cured disease
G Pollara, CT Turner, J Rosenheim, A Chandran, LC Bell, A Khan, A Patel, LF Peralta, A Folino, A Akarca, C Venturini, T Baker, S Ecker, FL Ricciardolo, T Marafioti, C Ugarte-Gil, DA Moore, BM Chain, GS Tomlinson, M Noursadeghi |
Science Translational Medicine | 2021 |
Th22 Cells Are a Major Contributor to the Mycobacterial CD4 + T Cell Response and Are Depleted During HIV Infection
R Bunjun, FM Omondi, MS Makatsa, R Keeton, JM Wendoh, TL Müller, CS Prentice, RJ Wilkinson, C Riou, WA Burgers |
Journal of immunology (Baltimore, Md. : 1950) | 2021 |
Lung Epithelial Signaling Mediates Early Vaccine-Induced CD4 + T Cell Activation and Mycobacterium tuberculosis Control
S Das, ND Marin, E Esaulova, M Ahmed, A Swain, BA Rosa, M Mitreva, J Rangel-Moreno, MG Netea, LB Barreiro, M Divangahi, MN Artyomov, D Kaushal, SA Khader, S Ehrt |
mBio | 2021 |
Advancing Adjuvants for Mycobacterium tuberculosis Therapeutics
AB Enriquez, A Izzo, SM Miller, EL Stewart, RN Mahon, DJ Frank, JT Evans, J Rengarajan, JA Triccas |
Frontiers in immunology | 2021 |
Classical CD4 T cells as the cornerstone of antimycobacterial immunity
J Morgan, K Muskat, R Tippalagama, A Sette, J Burel, CS Arlehamn |
Immunological Reviews | 2021 |
Mesenchymal Stem Cell Protects Injured Renal Tubular Epithelial Cells by Regulating mTOR-Mediated Th17/Treg Axis
Y Luo, J Guo, P Zhang, YC Cheuk, Y Jiang, J Wang, S Xu, R Rong |
Frontiers in immunology | 2021 |
Characterizing Early T Cell Responses in Nonhuman Primate Model of Tuberculosis
R Sharan, DK Singh, J Rengarajan, D Kaushal |
Frontiers in immunology | 2021 |
Multimodally profiling memory T cells from a tuberculosis cohort identifies cell state associations with demographics, environment and disease
A Nathan, JI Beynor, Y Baglaenko, S Suliman, K Ishigaki, S Asgari, CC Huang, Y Luo, Z Zhang, K Lopez, CS Arlehamn, JD Ernst, J Jimenez, RI Calderón, L Lecca, IV Rhijn, DB Moody, MB Murray, S Raychaudhuri |
Nature Immunology | 2021 |
Reduced CCR6+IL-17A+Treg Cells in Blood and CCR6-Dependent Accumulation of IL-17A+Treg Cells in Lungs of Patients With Allergic Asthma
X Shen, H Zhang, H Xie, L Chen, S Li, J Zheng, R Chai, Z Wang, Y Zang, S He |
Frontiers in immunology | 2021 |
Prophylactic efficacy against Mycobacterium tuberculosis using ID93 and lipid-based adjuvant formulations in the mouse model
SL Baldwin, VA Reese, SE Larsen, E Beebe, J Guderian, MT Orr, CB Fox, SG Reed, RN Coler, AA Izzo |
PloS one | 2021 |
A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guérin
JS Woodworth, HS Clemmensen, H Battey, K Dijkman, T Lindenstrøm, RS Laureano, R Taplitz, J Morgan, C Aagaard, I Rosenkrands, CS Arlehamn, P Andersen, R Mortensen |
Nature Communications | 2021 |
Complement activation induces excessive T cell cytotoxicity in severe COVID-19
P Georg, R Astaburuaga-García, L Bonaguro, S Brumhard, L Michalick, L Lippert, T Kostevc, C Gäbel, M Schneider, M Streitz, V Demichev, I Gemünd, M Barone, P Tober-Lau, E Helbig, D Hillus, L Petrov, J Stein, H Dey, D Paclik, C Iwert, M Mülleder, S Aulakh, S Djudjaj, R Bülow, H Mei, A Schulz, A Thiel, S Hippenstiel, A Saliba, R Eils, I Lehmann, M Mall, S Stricker, J Röhmel, V Corman, D Beule, E Wyler, M Landthaler, B Obermayer, S von Stillfried, P Boor, M Demir, H Wesselmann, N Suttorp, A Uhrig, H Müller-Redetzky, J Nattermann, W Kuebler, C Meisel, M Ralser, J Schultze, A Aschenbrenner, C Thibeault, F Kurth, L Sander, N Blüthgen, B Sawitzki |
Cell | 2021 |
Anti-retroviral therapy does not reduce tuberculosis reactivation in a tuberculosis-HIV co-infection model
Shashank R. Ganatra, Allison N. Bucsan, Xavier Alvarez, Shyamesh Kumar, Ayan Chatterjee, Melanie Quezada, Abigail I. Fish, Dhiraj K. Singh, Bindu Singh, Riti Sharan, Tae-Hyung Lee, Uma Shanmugasundaram, Vijayakumar Velu, Shabaana A. Khader, Smriti Mehra, Jyothi Rengarajan, Deepak Kaushal |
Journal of Clinical Investigation | 2020 |